Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05238558
Title Safety and Immune Response to FMPV-1
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Hubro Therapeutics AS
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.